- Q1. What is the business of Virupaksha Organics Limited?
It is an R&D‑driven Indian pharmaceutical company that manufactures active pharmaceutical ingredients (APIs), key starting materials (KSMs) and intermediates, and offers contract development and manufacturing services globally. - Q2. Why is the company raising funds via IPO?
Virupaksha Organics is raising funds via IPO to fund capacity expansion at multiple manufacturing units, prepay borrowings and to accelerate growth. - Q3. What is the size of the issue and where will it list?
The issue size of the IPO is approx ₹ 740 crore. It will be listed on the BSE & NSE platform. - Q4. What are the risks to an investor?
Risks to invest in the IPO is it’s regulatory compliance challenges, demand fluctuations in core therapeutic segments, operational and quality control risks, and reliance on customer relationships. - Q5. What are the potential upsides?
Potential upsides to invest in the IPO is it’s expanding global API demand, diversified product portfolio, strong international customer base, and enhanced production capacity post‑IPO. - Q6. How to apply for the IPO?
You can apply online through ASBA via net banking or UPI‑enabled IPO applications on broker platforms during the subscription window once announced. - Q 7. When is the tentative listing date?
Expected listing date is not yet announced.
Upcoming
Virupaksha Organics Limited
0
IPO Score
0
*Score varies on actual price
Virupaksha Organics Limited is an R&D-driven Indian pharmaceutical company engaged in the manufacturing of active pharmaceutical ingredients (APIs), key starting materials (KSMs) and intermediates, and also provides contract development & manufacturing services to global pharma companies. Its products span multiple therapeutic areas and serve customers in over 100 countries, supported by six manufacturing units in Telangana and Karnataka. The company has filed its DRHP with SEBI for an IPO to raise up to ₹ 740 crore via a fresh issuance of equity shares.
Virupaksha Organics Limited was incorporated in the year 1997.Mr. Mr. Chandra Mouliswar Reddy Gangavaram is the Managing Director of the company.
It offers manufacturing of small molecule active pharmaceutical ingredients (APIs), key starting materials (KSMs), and pharmaceutical intermediates, along with contract development and manufacturing (CDMO) services for global pharma clients.It serves over 550 customers in more than 100 countries, including major multinational pharmaceutical companies.
Subscription date to apply for Virupaksha Organics Limited is yet to be announced. Price band for the IPO is yet to be declared.
Revenue, PAT, EBITDA
|
Year
|
2025
|
|---|---|
|
Networth
|
₹ 456.6 Cr
|
|
Revenue
|
₹ 811.7 Cr
|
|
EBITDA
|
₹ 144.2 Cr
|
|
PAT
|
₹ 78.7 Cr
|
|
EBITDA Margin
|
~17.77%
|
|
PAT Margin
|
~9.70%
|
|
Face Value
|
Rs.10 per Equity Share
|
IPO Important Dates
|
#
|
Date
|
|---|---|
|
Open Date
|
TBA
|
|
Close Date
|
TBA
|
|
Anchor Investor Bidding
|
TBA
|
|
Allotment Date
|
TBA
|
|
Refunds& Demat Credit
|
TBA
|
|
Tentative Listing Date
|
TBA
|
Use Of Proceeds
|
Purpose
|
Amount
|
|---|---|
|
Borrowing payment
|
~ ₹ 195 Cr
|
|
Capacity Expansion
|
~ ₹ 360 Cr
|
|
-
|
-
|
|
-
|
-
|
|
-
|
-
|
|
General Corporate Purpose
|
Balance
|
Financial Data
|
#
|
2023
|
2024
|
2025
|
|---|---|---|---|
|
Revenue (₹ Cr)
|
645
|
766
|
812
|
|
PAT (₹ Cr)
|
43
|
74
|
79
|
|
Asset (₹ Cr)
|
602
|
697
|
952
|
|
Net Worth (₹ Cr)
|
210
|
275
|
457
|
IPO Grey Market Premium
|
Date
|
IPO Price
|
IPO GMP
|
Profit Per Lot
|
|---|---|---|---|
|
08-Aug
|
₹ –
|
₹ –
|
₹ –
|
|
07-Aug
|
₹ –
|
₹ –
|
₹ –
|
|
06-Aug
|
₹ –
|
₹ –
|
₹ –
|
|
05-Aug
|
₹ –
|
₹ –
|
₹ –
|
|
04-Aug
|
₹ –
|
₹ –
|
₹ –
|
Promoters – Pre offer equity (Approx)
|
Promoters
|
% Shares
|
|---|---|
|
Vedavathi Gangavaram
|
~17.25%
|
|
Gangavaram Sri Lakshmi
|
~9.98%
|
|
G Sri Vidya
|
~9.49%
|
|
Chandra Mouliswar Reddy Gangavaram
|
~9.14%
|
|
Balasubba Reddy Mamilla
|
~2.43%
|
|
-
|
-
|
Lot Size details
|
Application Type
|
Lot Size
|
No. of Lot
|
No. of Shares
|
Investment Amount
|
|---|---|---|---|---|
|
Retail (Min)
|
–
|
1
|
–
|
₹ –
|
|
Retail (Max)
|
–
|
13
|
–
|
₹ –
|
|
HNI (Min)
|
–
|
14
|
–
|
₹ –
|
|
HNI (Max)
|
–
|
66
|
–
|
₹ –
|
|
Big HNI (Min)
|
–
|
67
|
–
|
₹ –
|
Key Performance Index (KPI)
|
ROE
|
00
|
|---|---|
|
ROCE
|
00
|
|
RoNW
|
00
|
JOIN OUR SOCIAL-MEDIA PLATFORMS TO STAY UPDATED
